Compass PathwaysMEX:CMPSN 14 Current Ratio is 3.32 as of Mar. 2026, which is 77% below its 10-year median of 14.14. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Compass Pathways ranks better than 80.97% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Compass Pathways's current ratio for the quarter that ended in Mar. 2026 was 3.32.
Compass Pathways has a current ratio of 3.32. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Compass Pathways's Current Ratio or its related term are showing as below:
MEX:CMPSN'
s Current Ratio Range Over the Past 10 Years
Min: 0.77 Med: 14.14 Max: 42.82
Current: 3.32
During the past 8 years, Compass Pathways's highest Current Ratio was 42.82. The lowest was 0.77. And the median was 14.14.
MEX:CMPSN's Current Ratio is ranked better than 80.97% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs MEX:CMPSN: 3.32
Compass Pathways (MEX:CMPSN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Compass Pathways Current Ratio Related Terms
Compass Pathways Current Ratio Historical Data
* Premium members only.
The historical data trend for Compass Pathways's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CMPSN vs MD, SGRY, ADUS: Current Ratio Comparison
For the Medical Care Facilities subindustry, Compass Pathways's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compass Pathways Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Current Ratio distribution charts can be found below:
* The bar in red indicates where Compass Pathways's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Compass Pathways (MEX:CMPSN) has a Current Ratio of 3.32 as of Mar. 2026. This is 77% below median its historical median of 14.14. Over the past decade, Compass Pathways' Current Ratio has ranged from 0.77 to 42.82. According to the industry distribution chart, Compass Pathways ranks #130 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 19%.
Is Compass Pathways' Current Ratio too high?
Compass Pathways' current Current Ratio of 3.32 is 77% below median its 10-year median of 14.14. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 42.82. The Healthcare Providers & Services industry median Current Ratio is 1.47. Compass Pathways' value of 3.32 is 125.9% above this industry median. Based on the distribution chart, Compass Pathways ranks #130 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Current Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Compass Pathways ranks #130 out of 683 companies for Current Ratio. This places Compass Pathways in the top 19% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Compass Pathways' value of 3.32 is 125.9% above this benchmark. Historically, Compass Pathways' own Current Ratio has ranged from 0.77 to 42.82 over the past decade. While the company's 10-year median is 14.14 vs. the industry median of 1.47, Compass Pathways has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compass Pathways's current Current Ratio of 3.32 is 125.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compass Pathways's current Current Ratio is 3.32, which is 77% below median its own 10-year median of 14.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Current Ratio of 3.32. The current Current Ratio is 3.32, which is 77% below median its 10-year median of 14.14 and 125.9% above the Healthcare Providers & Services industry median of 1.47. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Current Ratio is 3.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score
Get the complete analysis for MEX:CMPSN
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CMPSN has been successfully added to your 
